Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (14)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Schiavello, T.
Right arrow Articles by Thomas, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schiavello, T.
Right arrow Articles by Thomas, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2001) 16: 2323-2327
© 2001 European Renal Association-European Dialysis and Transplant Association

Angiotensin-converting enzyme activity and the ACE Alu polymorphism in autosomal dominant polycystic kidney disease

Tina Schiavello1, Valerie Burke2, Nadia Bogdanova3, Piotr Jasik4, Steve Melsom5, Neil Boudville6, Ken Robertson7, Dora Angelicheva1, Bernd Dworniczak3, Marta Lemmens3, Juergen Horst3, Vassil Todorov8, Dimitar Dimitrakov9, Wladyslaw Sulowicz4, Andrzej Krasniak4, Tomasz Stompor4, Lawrence Beilin2, Joachim Hallmayer10, Luba Kalaydjieva1,11 and Mark Thomas6,

1 Centre for Human Genetics, Edith Cowan University, Joondalup, Perth, WA, 2 University Department of Medicine, University of Western Australia, Medical Research Foundation Building, Perth, WA, 3 Institut für Humangenetik, WW-U, Münster, Germany, 4 Department of Nephrology, Jagiellonian University, Cracow, Poland, 5 Department of Radiology, 6 Department of Nephrology, 7 Department of Biochemistry, Royal Perth Hospital, Perth, WA, 8 Clinic of Nephrology and Hemodialysis, University Hospital, Pleven, Bulgaria, 9 Clinic of Nephrology and Hemodialysis, University Hospital, Plovdiv, Bulgaria, 10 Centre for Clinical Research in Neuropsychiatry, Graylands Hospital, Perth, WA and 11 Western Australian Institute for Medical Research, QEII Medical Centre, Nedlands, Perth, WA, Australia

Background. Previous studies concerning Alu I/D polymorphism in the ACE gene and ADPKD severity have used the Alu genotypes as a representative of the true biological variable, namely ACE activity. However, wide individual and ethnic differences in the proportion of variance in ACE activity explained by the I/D genotype may have confounded these studies. This investigation examines the association between ADPKD severity and ACE in terms of plasma enzyme activity and I/D genotypes in individuals from three different countries.

Methods. Blood samples were collected from 307 ADPKD patients (116 Australian, 124 Bulgarian and 67 Polish) for determination of ACE activity levels and I/D genotypes. Chronic renal failure (CRF) was present in 117 patients and end-stage renal failure (ESRF) in 68 patients.

Results. ACE activity was related to the I/D genotype, showing a dosage effect of the D allele (P=0.006). The proportion of variance due to the Alu polymorphism was 14%. No difference in ACE activity and I/D genotype distribution was found between patients with CRF versus normal renal function (P=0.494; P=0.576) or between those with ESRF versus those without ESRF (P=0.872; P=0.825). No effect of the I/D genotype on age at development and progression to renal failure (CRF; ESRF) was detected in the overall group, and in subgroups based on ethnic origin, linkage status and sex.

Conclusion. ACE is not likely to play a role as a determinant of ADPKD phenotype severity.

Keywords: autosomal dominant polycystic kidney disease; angiotensin converting enzyme; chronic renal failure; end-stage renal failure

Correspondence and offprint requests to: Mark Thomas, Department of Nephrology, Royal Perth Hospital, GPO Box X2213, Perth, Western Australia 6001, Australia. Email: Mark.Thomas{at}health.wa.gov.au


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
B. Tazon-Vega, M. Vilardell, L. Perez-Oller, E. Ars, P. Ruiz, O. Devuyst, X. Lens, P. Fernandez-Llama, J. Ballarin, and R. Torra
Study of candidate genes affecting the progression of renal disease in autosomal dominant polycystic kidney disease type 1
Nephrol. Dial. Transplant., June 1, 2007; 22(6): 1567 - 1577.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
T. V. Pereira, A. C. F. Nunes, M. Rudnicki, R. Magistroni, A. Albertazzi, A. C. Pereira, and J. E. Krieger
Influence of ACE I/D gene polymorphism in the progression of renal failure in autosomal dominant polycystic kidney disease: a meta-analysis
Nephrol. Dial. Transplant., November 1, 2006; 21(11): 3155 - 3163.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
A. D. Paterson, R. Magistroni, N. He, K. Wang, A. Johnson, P. R. Fain, E. Dicks, P. Parfrey, P. St. George-Hyslop, and Y. Pei
Progressive Loss of Renal Function Is an Age-Dependent Heritable Trait in Type 1 Autosomal Dominant Polycystic Kidney Disease
J. Am. Soc. Nephrol., March 1, 2005; 16(3): 755 - 762.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
A. Persu, O. El-Khattabi, T. Messiaen, Y. Pirson, D. Chauveau, and O. Devuyst
Influence of ACE (I/D) and G460W polymorphism of {alpha}-adducin in autosomal dominant polycystic kidney disease
Nephrol. Dial. Transplant., October 1, 2003; 18(10): 2032 - 2038.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
R. Magistroni, N. He, K. Wang, R. Andrew, A. Johnson, P. Gabow, E. Dicks, P. Parfrey, R. Torra, J. L. San-Millan, et al.
Genotype-Renal Function Correlation in Type 2 Autosomal Dominant Polycystic Kidney Disease
J. Am. Soc. Nephrol., May 1, 2003; 14(5): 1164 - 1174.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.